C. Laezza

Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.

T. Bisogno, V. Di Marzo, D. Melck, 2000, Endocrinology.